View Press Releases
-
Biomaterials, Another Key Player in Advanced Drug Delivery Systems, Interact Seamlessly with Biological Systems, Facilitating the Controlled Release of Medications
In the fight against infectious diseases like HIV/AIDS, tuberculosis, and viral hepatitis, scientists are turning to advanced drug delivery for more effective treatments. These systems use tiny particles called nanoparticles to carry antiviral and antimicrobial drugs directly to the infected tissues in the body. By doing this, they can target the specific areas where the viruses or bacteria are causing harm while reducing the risk of side effects in other body parts.
Feb 18, 2024
-
CD BioSciences Announces Its Self-Developed Alginate Products, Looking to Fulfill Research Needs
CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.
Feb 17, 2024
-
New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients
New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients
Feb 14, 2024
-
SinguLab® Announces Integration with PointClickCare
Precision medicine and diagnostics solutions company SinguLab has partnered with PointClickCare Technologies Inc., provider of a cloud-based software platform for the senior care continuum, to improve precision care capabilities and access in the long-term and post-acute care (LTPAC) space.
Feb 12, 2024
-
Eagle Product Inspection Highlights the Pack 320 PRO X-ray Machine
Superior x-ray inspection of high-speed flow-wrap lines
Feb 14, 2024
-
REMEDI8 Highlights Mobile Containment Unit for Infection Control in the Healthcare Industry
HEPA-10X mitigates the spread of infection in high-risk healthcare environments
Feb 13, 2024
-
Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds
Feb 13, 2024
-
Optibrium enables collaborative design in its StarDrop platform
Optibrium today announced the release of StarDrop 7.6, the latest version of its platform for small molecule design, optimisation and analysis. As part of the release, Optibrium introduces a new extension, Idea Tracker, with which medicinal chemists can now easily trace molecular design and optimisation decisions through every step of the complex discovery process, from idea conception to selecting candidates for synthesis.
Feb 14, 2024
-
PrecisionLife and Metrodora Institute Partner to Accelerate the Diagnosis and Treatment of Long COVID, ME/CFS, and other Chronic Conditions
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.
Feb 14, 2024
-
Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test
Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test
Feb 12, 2024
-
Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation
Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation
Feb 12, 2024
-
Monoclonal Antibodies Stand as Beacons of Hope in Cancer Treatment, Offering Remarkable Advancements in the Fight Against this Relentless Disease!
In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.
Feb 11, 2024
-
HM Lord-Lieutenant of Cambridgeshire Opens Domainex’s New Biology Centre of Excellence and Presents the King’s Award for Enterprise
Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.
Feb 12, 2024
-
AES Clean Technology enhances cleanroom construction capabilities through new senior appointment
-
BioTeam Awarded 3 Year NIH Contract to Advance Genomics Research
BioTeam, Inc. has been awarded a contract by the National Human Genome Research Institute (NHGRI) to enhance its data ecosystem, accelerating genomic discoveries and improving human health outcomes.
Feb 7, 2024
-
Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies
Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.
Feb 7, 2024
-
ZeOmega Named Best in KLAS® for Payer Care Management Solutions in 2024
Today ZeOmega, a population health management company, was named Best in KLAS for Payer Care Management Solutions for the third consecutive year. The newly released 2024 Best in KLAS: Software & Services Report recognized ZeOmega as a leader in its market category. This designation follows a record growth year in 2023 that included: 94% client retention, 16% client base expansion New tech partners (such as Microsoft) to enhance automation capabilities Product innovations and AI implementations that address care quality, utilization management, member engagement, and risk adjustment
Feb 6, 2024
-
Watson-Marlow to demonstrate latest fluid path technologies at MD&M West
Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.
Feb 6, 2024
-
Cotiviti Named 2024 Best in KLAS® for Payer Quality Measurement and Reporting
Cotiviti announced they won 2024 Best in KLAS: Software & Services for its Quality Intelligence solution, which enables health plans to track, monitor, and improve quality compliance. With top feedback from its clients and other healthcare executives, Cotiviti earned the highest ratings in five of KLAS’s Customer Experience Pillars.
Feb 6, 2024
-
Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Rocky Mountain and ISPE CaSA
Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions
Feb 6, 2024